CYP2C9 polymorphism in five autochthonous population of the same geographic area (Spanish Pyrenees)

被引:6
作者
Borobia, Alberto M. [1 ]
Maria Lopez-Parra, Ana [2 ]
Tabares, Beatriz [1 ]
Ramirez, Elena [1 ]
Baeza, Carlos [2 ]
Arroyo-Pardo, Eduardo [2 ]
Carcas, Antonio J. [1 ]
机构
[1] Univ Autonoma Madrid, Fac Med, Hosp Univ La Paz, Serv Farmacol Clin, Madrid, Spain
[2] Univ Complutense Madrid, Fac Med, Dept Toxicol & Legislac Sanitaria, Madrid, Spain
关键词
CYP2C9; Polymorphism; Autochthonous population; GENETIC POLYMORPHISMS; CYTOCHROME-P450; CYP2C9; ALLELIC VARIANTS; WARFARIN; RISK; PHARMACOKINETICS; PHARMACOGENETICS; SENSITIVITY; ASSOCIATION; FREQUENCIES;
D O I
10.1016/j.phrs.2008.10.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To evaluate the frequency of CYP2C9 polymorphisms in a cohort of Caucasians (Spanish Pyrenees), previously classified in autochthonous populations. Methods: Blood samples from 154 anonymous volunteer donors were collected. All the individuals were autochthonous to their respective populations (four grandparents born in the region): 23 from Valle de Aran (Lerida), 29 from Alto Urgel (Lerida), 32 from La Cerdana (Gerona), 30 from Jacetania (Huesca) and 40 from Cinco Villas (Navarra). The analyses for allelic mutation, CYP2C9*2 and CYP2C9*3, were identified with Taqman (R) Allelic Discrimination kits. Results: No statistical differences were found when allelic frequencies in the five autochthonous populations were compared. Frequency distribution of genotypic classes (wt/wt, wt/mut and mut/mut) in Alto Urgel was different from that in La Cerdana, Cinco Villas and Jacetania samples. Comparison of Pyrenean and other European populations through exact test revealed significant differences in the distribution of genotypic classes: Alto Urgel, Barcelona, and Croatia yielded the highest significant differences. According to the exact test these populations were pooled in four groups. This classification produced a statistically significant percentage of variation explained by differences among groups (1.94%, P = 0.036), but not by differences among populations within groups (P = 0.914), although most of the percentage of variance is explained by differences within populations (97.46%, P < 0.001). Conclusion: This study increases the evidence of intra-population genotypic variability and highlights the significant genotypic heterogeneity when different autochthonous populations are considered, despite no clear differences in allelic frequencies do exist. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:107 / 111
页数:5
相关论文
共 34 条
[1]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[2]   Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations [J].
Allabi, AC ;
Gala, JL ;
Desager, JP ;
Heusterspreute, M ;
Horsmans, Y .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (06) :653-657
[3]  
Arroyo-Pardo E., 2001, Rev. Esp. Antrop. Fis, V22, P81
[4]  
Bozina N, 2003, CROAT MED J, V44, P425
[5]   CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers [J].
Dorado, P ;
Berecz, R ;
Norberto, MJ ;
Yasar, Ü ;
Dahl, ML ;
LLerena, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (03) :221-225
[6]   Moving towards individualized medicine with pharmacogenomics [J].
Evans, WE ;
Relling, MV .
NATURE, 2004, 429 (6990) :464-468
[7]   Arlequin (version 3.0): An integrated software package for population genetics data analysis [J].
Excoffier, Laurent ;
Laval, Guillaume ;
Schneider, Stefan .
EVOLUTIONARY BIOINFORMATICS, 2005, 1 :47-50
[8]   High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population [J].
García-Martín, E ;
Martínez, C ;
Ladero, JM ;
Gamito, FJG ;
Agúndez, JAG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (01) :47-49
[9]   Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals [J].
Garcia-Martin, Elena ;
Martinez, Carmen ;
Ladero, Jose M. ;
Agundez, Jose A. G. .
MOLECULAR DIAGNOSIS & THERAPY, 2006, 10 (01) :29-40
[10]   Clinical relevance of genetic polymorphisms in the human CYP2C subfamily [J].
Goldstein, JA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) :349-355